Palata, Jerry .

HRN: 26-18-77  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
CEFTRIAXONE 1G (VIAL)
04/06/2026
04/13/2026
IV
2g
Od
Nasopharyngeal Ca
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: